Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold

References

• (a) Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.;
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12.
   PubMed Web of Science ®Google Scholar
• (a) Carradori S, Mollica A, De Monte C, et al. Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis. Molecules 2015;20:5667–79.;
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 2018;28:713–21.
   PubMed Web of Science ®Google Scholar
• (a) Ronci M, Del Prete S, Puca V, et al. Identification and characterization of the α-CA in the outer membrane vesicles produced by Helicobacter pylori. J Enzyme Inhib Med Chem 2019;34:189–95.;
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat 2018;28:745–54.
   PubMed Web of Science ®Google Scholar
• (a) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77;
   PubMed Web of Science ®Google Scholar
  (b) Nocentini A, Supuran CT. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). Expert Opin Ther Pat 2018;28:729–40.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrase activators. Future Med Chem 2018;10:561–73;
   PubMed Web of Science ®Google Scholar
  (b) Kuchuk O, Tuccitto A, Citterio D, et al. pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma. Oncoimmunology 2018;7:e1445452.
   PubMed Web of Science ®Google Scholar
• (a) Ammazzalorso A, Carradori S, Angeli A, et al. Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies. J Enzyme Inhib Med Chem 2019;34:1051–61;
   PubMed Web of Science ®Google Scholar
  (b) Bouchouit M, Bouacida S, Zouchoune B, et al. Synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes. J Enzyme Inhib Med Chem 2018;33:1150–9.
   PubMed Web of Science ®Google Scholar
• (a) Koyuncu I, Tülüce Y, Slahaddin Qadir H, et al. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells. J Enzyme Inhib Med Chem 2019;34:703–11;
   PubMed Web of Science ®Google Scholar
  (b) Ramya PVS, Angapelly S, Angeli A, et al. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors. J Enzyme Inhib Med Chem 2017;32:1274–81.
   PubMed Web of Science ®Google Scholar
• (a) Mocan A, Carradori S, Locatelli M, et al. Bioactive isoflavones from Pueraria lobata root and starch: Different extraction techniques and carbonic anhydrase inhibition. Food Chem Toxicol 2018;112:441–7;
   PubMed Web of Science ®Google Scholar
  (b) Nescatelli R, Carradori S, Marini F, et al. Geographical characterization by MAE-HPLC and NIR methodologies and carbonic anhydrase inhibition of Saffron components. Food Chem 2017;221:855–63.
   PubMed Web of Science ®Google Scholar
• Mollica A, Macedonio G, Stefanucci A, et al. Five- and six-membered nitrogen-containing compounds as selective Carbonic Anhydrase activators. Molecules 2017;22:2178–90.
   Web of Science ®Google Scholar
• (a) D’Ascenzio M, Guglielmi P, Carradori S, et al. Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms. J Enzyme Inhib Med Chem 2017;32:51–9;
   PubMed Web of Science ®Google Scholar
  (b) Žuvela P, Liu JJ, Yi M, et al. Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes. J Enzyme Inhib Med Chem 2018;33:1430–43.
   PubMed Web of Science ®Google Scholar
• (a) Carradori S, Secci D, De Monte C, et al. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms. Bioorg Med Chem 2016;24:1095–105;
   PubMed Web of Science ®Google Scholar
  (b) Gulçin İ, Abbasova M, Taslimi P, et al. Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2017;32:1174–82.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88;
   PubMed Web of Science ®Google Scholar
  (b) Koyuncu I, Gonel A, Kocyigit A, et al. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells. J Enzyme Inhib Med Chem 2018;33:1137–49.
   PubMed Web of Science ®Google Scholar
• Maccallini C, Di Matteo M, Vullo D, et al. Indazole, pyrazole, and oxazole derivatives targeting Nitric Oxide Synthases and Carbonic Anhydrases. ChemMedChem 2016;11:1695–9.
   PubMed Web of Science ®Google Scholar
• (a) Weber CE, Kuo PC. The tumor microenvironment. Surg Oncol 2012;21:172–7;
   PubMed Web of Science ®Google Scholar
  (b) Stanica L, Gheorghiu M, Stan M, et al. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays. J Enzyme Inhib Med Chem 2017;32:1079–90.
   PubMed Web of Science ®Google Scholar
• Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011;11:671–7.
   PubMed Web of Science ®Google Scholar
• Parks SK, Chiche J, Pouyssegur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 2013;13:611–23.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27:963–70.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60;
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018;33:485–95.
   PubMed Web of Science ®Google Scholar
• Langella E, D'Ambrosio K, D'Ascenzio M, et al. A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes within carbonic anhydrase active site. Chem Eur J 2016;22:97–100.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio K, Carradori S, Monti SM, et al. Out of the active site binding pocket for carbonic anhydrase inhibitors. Chem Commun 2015;51:302–5.
   PubMed Web of Science ®Google Scholar
• Ferretti R, Carradori S, Guglielmi P, et al. Enantiomers of triclabendazole sulfoxide: analytical and semipreparative HPLC separation, absolute configuration assignment, and transformation into sodium salt. J Pharm Biomed Anal 2017;140:38–44.
   PubMed Web of Science ®Google Scholar
• Cirilli R, Guglielmi P, Formica FR, et al. The sodium salt of the enantiomers of ricobendazole: preparation, solubility and chiroptical properties. J Pharm Biomed Anal 2017;139:1–7.
   PubMed Web of Science ®Google Scholar
• Soeta T, Matsuzaki S, Ukaji Y. A one-pot O-sulfinative Passerini/oxidation reaction: synthesis of α-(sulfonyloxy)amide derivatives. J Org Chem 2015;80:3688–94.
   PubMed Web of Science ®Google Scholar
• (a) Carradori S, Pierini M, Menta S, et al. 3-(Phenyl-4-oxy)-5phenyl-4,5-dihydro-(1H)-pyrazole: a fascinating molecular framework to study the enantioseparation ability of the amylose (3,5-dimethylphenylcarbamate) chiral stationary phase. Part I. Structure-enantioselectivity relationships. J Chromatogr A 2016;1467:221–7;
   PubMed Web of Science ®Google Scholar
  (b) Pierini M, Carradori S, Menta S, et al. 3-(Phenyl-4oxy)-5-phenyl-4,5-dihydro-(1H)-pyrazole: A fascinating molecular framework to study the enantioseparation ability of the amylose (3,5-dimethylphenylcarbamate) chiral stationary phase. Part II. Solvophobic effects in enantiorecognition process. J Chromatogr A 2017;1499:140–8.
   PubMed Web of Science ®Google Scholar
• Sosi I, Barreteau H, Simcic M, et al. Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of D-glutamic acid. Eur J Med Chem 2011;46:2880–94.
   PubMed Web of Science ®Google Scholar
• Pandey SK, Mishra M, Sharma A, et al. Syntheses of low molecular hydroxamates as potent antiprotozoal and antifungal agents. Chem Biol Interface 2012;2:373–93.
   Google Scholar
• Adler MJ, Hamilton AD. Oligophenylenaminones as scaffolds for α-helix mimicry. J Org Chem 2011;76:7040–7.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Cheng HC. The power issue: determination of KB or Ki from IC50 – A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. J Pharmacol Toxicol Methods 2001;46:61–71.
   PubMed Web of Science ®Google Scholar
• Gieling RG, Babur M, Mamnani L, et al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J Med Chem 2012;55:5591–600.
   PubMed Web of Science ®Google Scholar
• Carradori S, Mollica A, Ceruso M, et al. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies. Bioorg Med Chem 2015;23:2975–81.
   PubMed Web of Science ®Google Scholar
• Labute P. Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins 2009;75:187–205.
   PubMed Web of Science ®Google Scholar
• Akdemir A, De Monte C, Carradori S, Supuran CT. Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme. J Enzyme Inhib Med Chem 2015;30:114–8.
   PubMed Web of Science ®Google Scholar
• Labute P. The generalized born/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area. J Comput Chem 2008;29:1693–8.
   PubMed Web of Science ®Google Scholar